West Pharmaceutical Servi... (WST)

NYSE: WST · Real-Time Price · USD

210.44

-0.85 (-0.40%)

At close: May 01, 2025, 3:52 PM

West Pharmaceutical Services Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	2.89B	2.95B	2.89B	2.83B	2.15B	1.84B	1.72B	1.6B	1.51B
Cost of Revenue	1.89B	1.82B	1.75B	1.66B	1.38B	1.23B	1.17B	1.09B	1.01B
Gross Profit	998.5M	1.13B	1.14B	1.18B	767.8M	605.7M	545.4M	512.6M	501.1M
Operating Income	569.9M	676M	734M	752.3M	406.9M	296.6M	240.3M	228.9M	196.8M
Interest Income	19.6M	28M	5.1M	1M	1.4M	3.8M	2.1M	1.3M	1.1M
Pretax Income	585.5M	698M	679.9M	748.9M	401.3M	291.8M	240.7M	222.4M	189.8M
Net Income	492.7M	593.4M	585.9M	661.8M	346.2M	241.7M	206.9M	150.7M	143.6M
Selling & General & Admin	338.5M	353.4M	316.9M	362.8M	302M	272.7M	262.9M	242.6M	239.8M
Research & Development	69.1M	68.4M	58.5M	52.8M	46.9M	38.9M	40.3M	39.1M	36.8M
Other Expenses	21M	31.5M	26.8M	7.9M	12M	2.4M	4.8M	-2M	-27.7M
Operating Expenses	428.6M	454M	402.2M	423.5M	360.9M	311.6M	303.2M	281.7M	276.6M
Interest Expense	3M	9M	7.9M	7.2M	6.8M	4.7M	6.3M	6.5M	7M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.32B	2.27B	2.15B	2.08B	1.74B	1.55B	1.48B	1.37B	1.28B
Income Tax Expense	107.5M	122.3M	114.7M	107.2M	72.5M	59M	41.4M	80.9M	54.4M
Shares Outstanding (Basic)	73M	74.3M	74.4M	74.4M	73.9M	74M	73.9M	73.9M	73.3M
Shares Outstanding (Diluted)	73.7M	75.3M	75.8M	76.3M	75.8M	75.4M	75.4M	75.8M	75M
EPS (Basic)	6.75	7.99	7.88	8.90	4.68	3.27	2.80	2.04	1.96
EPS (Diluted)	6.69	7.88	7.73	8.67	4.57	3.21	2.74	1.99	1.91
EBITDA	743.9M	844.1M	887.9M	895.2M	531.7M	399.4M	355.3M	335.9M	319.6M
EBIT	588.5M	707M	687.8M	757.1M	409.5M	300.3M	249.1M	230.2M	197.9M
Depreciation & Amortization	155.4M	137.3M	120.6M	122.3M	109.1M	103.4M	104.4M	96.7M	90.7M